GTR 98931698
Bids Are Invited For Price Registration For Eventual Acquisition Of Cancer Medicines And The Like, In Order To Meet The Needs Of Professor Alberto Antunes University Hospital, Linked To The Federal University Of Alagoas, Belonging To The Network Of The Brazilian Ebserh Hospital Services, For A Period Of 01 (One) Year, And May Be Extended For The Same Period, Provided The Advantageous Price Is Proven.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
98931698
Tendering Authority
Subscribe to view
Tender No
90027/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For Eventual Acquisition Of Cancer Medicines And The Like, In Order To Meet The Needs Of Professor Alberto Antunes University Hospital, Linked To The Federal University Of Alagoas, Belonging To The Network Of The Brazilian Ebserh Hospital Services, For A Period Of 01 (One) Year, And May Be Extended For The Same Period, Provided The Advantageous Price Is Proven.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
18-07-2025
Closed
Work Detail
Price Registration For Eventual Acquisition Of Cancer Medicines And The Like, In Order To Meet The Needs Of Professor Alberto Antunes University Hospital, Linked To The Federal University Of Alagoas, Belonging To The Network Of The Brazilian Ebserh Hospital Services, For A Period Of 01 (One) Year, And May Be Extended For The Same Period, Provided The Advantageous Price Is Proven.. Abiraterona Acetate, Leupportine Acetate, Megestrol Acetate, Acid Zoledronic, Anastrozole, Bevacizumab, Bevacizumab, Bicalutamide, Bortezomibe, Carpecitabine, Carboplatin, Carboplatin, Cyclophosphamide, Cyclin, Cisplatin, Citarabine, Citarabine, Tamoxiphene Citrate, Cladribine, Chlorambuccila, Topotecan Hydrochloride, Anagragrace, Daunorrubicin, Dexrazoxane, Doxorrubicin Hydrochloride, Hydrochloride, Doxorrubicin Chloride, Hydrochloride, Gencitabine Chloridrate, Yarrubicin Hydrochloride, Irinotecan Hydrochloride, Nilotinib, Dacarbazine, Dasatinib, Dasatinib, Doctaxel, Docetaxel, Ethoposite, Exestane, Fluoruracil, Fludarabine Phosphate, Fulvestrant, Gefitinib, Vinorelbine, Vinorelbine, Hydroxyurea, Iphosphamide, Melphala, Mesna, Mesna, Mercaptopine, Imatinib Mesylate, Imatinib Mesylate, Methotrexate, Methotrexate, Methotrexate, Oxaliplastin, Paclitaxel, Paclitaxel, Sodium Pamidronate, Sulfate, Vimblastin, Vincristine, Mretinoin, Interferon, Asparaginase, Carmustine, Rituximab, Rituximab, Fluctamide, Azacitidinidinidin
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
5361564d-0ab9-466a-ab92-d56acff3a870.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.